Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, John M Masterson, Abhishek Venkataramana, Dmitry Khodyakov, Jennifer T Anger, Edwin Posadas, Howard Sandler, Stephen J Freedland, Brennan Spiegel, Timothy J Daskivich
BACKGROUND: Physician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language used when describing cancer prognosis, life expectancy, and side effects in relation to a physician's recommendation for aggressive (surgery/radiation) or nonaggressive (active surveillance/watchful waiting) treatment. METHODS: A qualitative analysis was performed on transcribed treatment consultations of 40 men with low- and intermediate-risk prostate cancer across 10 multidisciplinary providers...
February 12, 2024: Medical Decision Making: An International Journal of the Society for Medical Decision Making